Earnings Feed
Start Free
Home/Filings/4/0001638727-18-000003
4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001638727-18-000003

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 4:16 PM ET

Size

9.0 KB

Accession

0001638727-18-000003

Insider Transaction Report

Form 4
Period: 2010-01-20
Lexaria Bioscience Corp.LXRP
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
  • Award

    Common Shares

    2018-08-31$2.07/sh+36,500$75,555→ 1,622,250 total(indirect: Private holding company)
Holdings

  • Stock Options

    Exercise: $0.11From: 2016-04-15Exp: 2021-04-15→ Common Shares (300,000 underlying)
    850,000

  • Common Shares

    (indirect: Private holding company)
    1,585,750

  • Stock Options

    Exercise: $0.09From: 2015-03-26Exp: 2020-03-26→ Common Shares (550,000 underlying)
    550,000

  • Stock Options

    Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ Common Shares (400,000 underlying)
    1,250,000

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001638727

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:16 PM ET
Size
9.0 KB
View on SEC.gov